Literature DB >> 8399935

Clinical overview of typical Mycoplasma pneumoniae infections.

W A Clyde1.   

Abstract

A number of clinical and epidemiological factors permit the tentative identification of Mycoplasma pneumoniae infections. These selective factors can be considered the mainstay of diagnosis because they facilitate intelligent and efficient use of laboratory tests. The laboratory, in turn, through identification of the causative agent, augments both clinical and epidemiological data. The laboratory can better serve its purpose as more rapid, sensitive, and specific diagnostic methods come into use.

Entities:  

Mesh:

Year:  1993        PMID: 8399935

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  45 in total

1.  Rationalised prescribing for community acquired pneumonia: a closed loop audit.

Authors:  H Clements; T Stephenson; V Gabriel; T Harrison; M Millar; A Smyth; W Tong; C J Linton
Journal:  Arch Dis Child       Date:  2000-10       Impact factor: 3.791

2.  Detection of Mycoplasma pneumoniae by real-time nucleic acid sequence-based amplification.

Authors:  K Loens; M Ieven; D Ursi; T Beck; M Overdijk; P Sillekens; H Goossens
Journal:  J Clin Microbiol       Date:  2003-09       Impact factor: 5.948

3.  Evaluation of 12 commercial tests and the complement fixation test for Mycoplasma pneumoniae-specific immunoglobulin G (IgG) and IgM antibodies, with PCR used as the "gold standard".

Authors:  Matthias F C Beersma; Kristien Dirven; Alje P van Dam; Kate E Templeton; Eric C J Claas; Herman Goossens
Journal:  J Clin Microbiol       Date:  2005-05       Impact factor: 5.948

4.  Mycoplasma pneumoniae Pneumonia with Worsening Pleural Effusion Despite Treatment with Appropriate Antimicrobials: Case report.

Authors:  Kowthar S Hassan; Ghalib Al-Khadouri
Journal:  Sultan Qaboos Univ Med J       Date:  2018-09-09

5.  Molecular approaches to diagnosis of pulmonary diseases due to Mycoplasma pneumoniae.

Authors:  M Abele-Horn; U Busch; H Nitschko; E Jacobs; R Bax; F Pfaff; B Schaffer; J Heesemann
Journal:  J Clin Microbiol       Date:  1998-02       Impact factor: 5.948

6.  Mycoplasma pneumoniae respiratory tract infections among Greek children.

Authors:  M Almasri; E Diza; A Papa; M Eboriadou; E Souliou
Journal:  Hippokratia       Date:  2011-04       Impact factor: 0.471

7.  Mycoplasma pneumoniae infection in primary care investigated by real-time PCR in England and Wales.

Authors:  V J Chalker; T Stocki; M Mentasti; D Fleming; C Sadler; J Ellis; A Bermingham; T G Harrison
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-02-12       Impact factor: 3.267

8.  Frequent detection of Mycoplasma pneumoniae in Bell's palsy.

Authors:  C Völter; J Helms; B Weissbrich; P Rieckmann; M Abele-Horn
Journal:  Eur Arch Otorhinolaryngol       Date:  2003-10-24       Impact factor: 2.503

9.  Cloning, expression, and immunological characterization of the P30 protein of Mycoplasma pneumoniae.

Authors:  Avanish Kumar Varshney; Rama Chaudhry; Sushil Kumar Kabra; Pawan Malhotra
Journal:  Clin Vaccine Immunol       Date:  2007-11-21

10.  Isolation of Mycoplasma pneumoniae from the human urogenital tract.

Authors:  M Goulet; R Dular; J G Tully; G Billowes; S Kasatiya
Journal:  J Clin Microbiol       Date:  1995-11       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.